Shojaei, PharmD, PhD, has joined Harrow as Chief Scientific Officer (CSO). With a remarkable career spanning 28 years in life sciences, Dr. Shojaei brings deep expertise in clinical development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback